Diabetes

FDA approves A1c test for diabetes diagnosis

(HealthDay)—The U.S. Food and Drug Administration has just cleared a hemoglobin A1c assay to be marketed for the diagnosis of diabetes, according to a May 24 press release issued by the agency.

Oncology & Cancer

A new microfluidic system could keep tabs on cancer treatment

Found in a patient's blood, circulating tumor cells, or CTCs, have powerful potential to indicate how well a cancer treatment is working and guide treatment decisions. Even so, CTC technologies have not yet been widely implemented ...

Medical research

New testing system predicts septic shock outcomes

More than 1.7 million Americans develop sepsis each year, and more than 270,000 die from it. The condition—which happens when the body has an extreme response to a bacterial or viral infection, causing a chain reaction ...

Gastroenterology

FDA approves first pill for fecal transplant therapy

The U.S. Food and Drug Administration on Wednesday approved the first pill form of fecal microbiota—similar to what's known as fecal transplant therapy—to treat the bacterial infection Clostridioides difficile, one of ...

Diseases, Conditions, Syndromes

New test IDs genotype of hepatitis C

(HealthDay)—A new test to help doctors identify the genotype of a person's hepatitis C infection has been approved by the U.S. Food and Drug Administration.

page 8 from 17